Emergency Access to Insulin Act of 2023
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Emergency Access to Insulin Act of 2023 is a House bill introduced in the 118th Congress aimed at addressing urgent access to insulin for individuals who require it. The bill was referred to the Subcommittee on Health but ultimately failed or expired without further legislative action. No official summary or full text is available, limiting detailed analysis of its provisions. The bill falls under the health policy area and appears intended to facilitate emergency insulin access, likely in response to public health concerns about insulin availability and affordability.
This bill sought to improve emergency access to insulin but did not advance beyond subcommittee referral and expired without passage.
- The bill is titled Emergency Access to Insulin Act of 2023 and was introduced in the House during the 118th Congress.
- It was referred to the Subcommittee on Health on December 17, 2024, but no further legislative action occurred.
- No official summary or full text is publicly available, limiting detailed understanding of its specific provisions.
['Individuals with diabetes requiring insulin', 'Healthcare providers involved in emergency care', 'Health agencies overseeing medication access']
['Lack of publicly available full text and summary limits clarity on implementation mechanisms and funding sources.', 'Without detailed provisions, oversight and enforcement mechanisms are unknown.', 'Potential cost implications for healthcare systems and insurers are not specified.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health but did not progress further. It is part of ongoing legislative efforts to address insulin access and affordability, a significant public health issue. The bill's failure to advance may reflect legislative priorities or procedural factors during the session.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Improved emergency access to insulin could reduce acute health crises related to insulin shortages or affordability issues.', 'Healthcare providers may need to adjust protocols to comply with any new emergency access provisions if enacted.', 'Potential shifts in insurance coverage policies or pharmacy practices related to insulin dispensing.']
The absence of a full bill text and official summary restricts transparency and public understanding of the bill's detailed provisions and potential impacts. The bill's failure to advance past subcommittee referral further limits oversight opportunities. Future legislative efforts on this topic would benefit from complete documentation to facilitate informed analysis and public engagement.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.